Eamon Drugs Private Limited

Eamon Drugs Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24114MP1985PTC003021 Incorporated 04 September 1985 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹15.64 Cr
▲ 24% YoY
Net profit · FY 2025
₹18.2 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹1.63 Cr
EBITDA margin 10.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹72.38 Lakh
Issued & subscribed
Open charges
₹4.2 Cr
Satisfied ₹2 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
11
Provident fund records

About Eamon Drugs Private Limited

Data last updated:

Eamon Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 September 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24114MP1985PTC003021. Its GSTIN is 23AAJCS3840C1ZP (Madhya Pradesh).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹72.38 Lakh. It was formerly known as Shyra Chemicals Private Limited and Midway Drugs Private Limited. It is led by directors including Rishabh Mandloi and Udit Sodani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 104 – A – 2 105 A – 1 Sect E Sanwer Road, Indore, Madhya Pradesh, India – 452001.

As per the financials filed for FY 2025, the company reported a revenue of ₹15.64 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹18.2 Lakh (net margin 1.2%) and EBITDA of ₹1.63 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 40% over five years.

The company has about 11 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Eamon Drugs. As per MCA filings, the company has open charges of ₹4.2 Cr and satisfied charges of ₹2 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 6 cases are pending.

Eamon Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0078267). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eamon-drugs-private-limited.business.site.

Company details

CIN U24114MP1985PTC003021
Registration Number 003021
Incorporation Date 04 September 1985
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0078267

Name history

Eamon Drugs has undergone 10 name changes throughout its history. The current legal name is Eamon Drugs Private Limited.

Company NameStatus
Eamon Drugs Private LimitedCurrent
Shyra Chemicals Private LimitedPrevious
Midway Drugs Private LimitedPrevious
Gm Drugs Private LimitedPrevious
Garichem Private LimitedPrevious
Glenochem Private LimitedPrevious
Garima Healthochem Private LimitedPrevious
Gairechem Private LimitedPrevious
Agchem Private LimitedPrevious
Pithampur Chemicals Private LimitedPrevious
Key People
Rishabh Mandloi Director Udit Sodani Director Mahendra Kumar Mandloi Director

Recognitions & Rankings of Eamon Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MP-23-0078267

Contact details

Eamon Drugs Private Limited's registered office is in Indore, Madhya Pradesh. Its website is eamon-drugs-private-limited.business.site. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    eamon-drugs-private-limited.business.site
  • Registered Address
    104 – A – 2 105 A – 1 Sect E Sanwer Road, Indore, Madhya Pradesh, India – 452001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Eamon Drugs Private Limited, buy the company report.

Comprehensive company report
Eamon Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Eamon Drugs operates one associated brand: Eamon Drugs. Each brand links to its own profile.

BrandDescriptionWebsite
Eamon Drugs
Eamon Drugs produces softgel capsules and ointments with quality focus.eamondrugs.com

Business activity

The main business activity of Eamon Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Eamon Drugs Private Limited, buy the company report.

Financials of Eamon Drugs Private Limited

FY 2025 filings available

Eamon Drugs Private Limited reported revenue of ₹15.64 Cr (up 24% YoY) for FY 2025.

Revenue · FY 2025
₹15.64 Cr ▲ 24%
Net profit · FY 2025
₹18.2 Lakh margin 1.2%
EBITDA · FY 2025
₹1.63 Cr margin 10.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 22%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 44%
5 years · compounded
▲ 45%

Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 24% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.63 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹18.2 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.4%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Eamon Drugs Private Limited, buy the company report.

Board of directors of Eamon Drugs Private Limited

Eamon Drugs has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rishabh MandloiDirector14 Jul 20206 Years 3 MonthsCurrent
Udit Sodani
Also directs: Ishika Consultancy Services Pvt Ltd
Director25 Jan 20188 Years 9 MonthsCurrent
Mahendra Kumar MandloiDirector25 Jan 20188 Years 9 MonthsCurrent
View all directors

Peer comparison

Eamon Drugs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Suma Pharmaceuticals Private Limited₹15.75 Cr (FY 2024)9.0%Ambernath, Maharashtra, India
Syntho Pharmaceuticals Private Limited₹15.7 Cr (FY 2025)-3.0%Uttar Pradesh, India
Hfa Formulations Private Limited₹15.65 Cr (FY 2024)42.0%Chennai, Tamil Nadu, India
Eamon Drugs Private Limitedthis company₹15.64 Cr (FY 2025)₹18.2 Lakh1.2%24.0%11Indore, Madhya Pradesh, India
Zuche Pharmaceuticals Private Limited₹15.59 Cr (FY 2025)-14.0%Delhi, India
Jagannath Chemical and Pharmaceutical Works Pvt Ltd₹15.58 Cr (FY 2024)25.0%Cuttack, Odisha, India
Bhanu Healthcare Private Limited₹15.58 Cr (FY 2022)18.0%Mumbai, Maharashtra, India
Agma Packaging Private Limited₹15.57 Cr (FY 2025)-17.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Eamon Drugs Private Limited, buy the company report.

Auditor

Eamon Drugs Private Limited is audited by DEVVRAT TAPARIA & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
DEVVRAT TAPARIA & COFY 2023017914C

Shareholding

The shareholding of Eamon Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Eamon Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.2 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Canara Bank₹4.00 Cr
Others₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Nov 2025101193335Canara Bank₹4 CrOpen
11 Oct 2024100995985Others₹20 LakhOpen
07 Mar 2023100685182Others₹2 CrSatisfied

To see the full charge records of Eamon Drugs Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Eamon Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Eamon Drugs Private Limited has a workforce of 11 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
11
Active EPFO establishments
1
Employee growth
-15.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2711
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23

To see the full employee and EPFO history of Eamon Drugs Private Limited, buy the company report.

GST

Eamon Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAJCS3840C1ZPMadhya PradeshActive02 Apr 2018

To see the full GST registrations and return filing status of Eamon Drugs Private Limited, buy the company report.

Recent activity

Eamon Drugs Private Limited has 17 board changes on record since 2004: 10 appointments and 7 cessations. The latest: Mamta Mandloi ceased to be Director on 14 Jul 2020.

Charges
A charge with Canara Bank amounted to Rs. 4.00 Cr with Charge ID 101193335 was registered on 12 Nov 2025.
Charges
A charge registered on 07 Mar 2023 via Charge ID 100685182 with Others was fully satisfied on 12 Nov 2025.
AGM
Eamon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Eamon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100995985 was registered on 11 Oct 2024.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100685182 was registered on 07 Mar 2023.
Ceased
Mamta Mandloi ceased to be Director.
Appointed
Rishabh Mandloi was appointed as Director.
Ceased
Harish Gangwani ceased to be Additional Director.
Ceased
Ajay Gangwani ceased to be Additional Director.
Ceased
Ayush Kabra ceased to be Director.
Appointed
Mahendra Kumar Mandloi was appointed as Director.

12 earlier events are in the company report.

Frequently asked questions

Eamon Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 September 1985 (41+ years old) and is registered under CIN U24114MP1985PTC003021.

Eamon Drugs has 3 current directors:

The latest financial statements of Eamon Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Eamon Drugs is 23AAJCS3840C1ZP, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Eamon Drugs is U24114MP1985PTC003021. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Eamon Drugs has 6 court cases on record: 6 filed against it. 6 are pending.

Eamon Drugs was incorporated on 04 September 1985, making it 41+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Eamon Drugs by revenue are Suma Pharmaceuticals Private Limited, Syntho Pharmaceuticals Private Limited, Hfa Formulations Private Limited, Zuche Pharmaceuticals Private Limited, Jagannath Chemical and Pharmaceutical Works Pvt Ltd and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mamta Mandloi ceased to be Director on 14 Jul 2020. Rishabh Mandloi was appointed as Director on 14 Jul 2020. Harish Gangwani ceased to be Additional Director on 29 Jan 2018. Eamon Drugs has 17 board changes on record in total.

Yes, Eamon Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0078267).

Eamon Drugs can be reached through the website eamon-drugs-private-limited.business.site. Its registered office is in Indore, Madhya Pradesh, India.